| Management target | Revenue 100.0% 3-4 years |
|---|
| Revenue growth | 19.22% YoY growth to 666 Cr. |
|---|---|
| Margins | EBITDA margins stable at 24.58%; gross margins compressed YoY. |
| Demand visibility | Healthy demand in fragrance and flavor value chains globally. |
| Management confidence | Highly confident, emphasizing 20% CAGR targets and structural strength. |
Growth
Revenue grew 19.22% YoY to 666 Cr, driven by volume and price increases across domestic and international markets.
Outlook
Targeting 5,000 Cr revenue and 1,000 Cr+ EBITDA in 3-4 years. Phase 1 expansion to 54,000 MT by Sept 2026.
Risks
Gross margin fell ~650 bps YoY; delayed Phase 1 capacity expansion; significant debt levels with 1.29 Net Debt/EBITDA.
Last quarter's promises, checked
Delivered
- Guided 20%+ EBITDA margins → delivered 25.76% FY26 (= BEAT)
- Guided PRIGIV JV profit in Q4 → delivered reported profits (= BEAT)
- Guided 20% revenue growth → delivered 21.73% FY26 (= BEAT)
Partly delivered
- Guided 117 days working capital cycle → delivered 117 days (FY26 target met, but current call notes high debt) (= PARTIAL)
Missed
- Guided Phase 1 Capex completion 30 June 2026 → delivered delayed to Sept 2026 (= MISS)
Earnings Call Transcript filed with BSE, NSE: PRIVISCL. Summary written with AI assistance from the document.
Privi Speciality Chemicals Ltd: key numbers
- Share price
- ₹3,506.30
- Market cap
- ₹13,697 Cr
- Revenue (annual)
- ₹2,564 Cr
- Net profit (annual)
- ₹327.5 Cr
- P/E (TTM)
- 39.1×Sector 37.2×
- Promoter holding
- 60.60%+0.00% QoQ
- FII holding
- 1.94%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Privi Speciality Chemicals Ltd
All →Privi Speciality Chemicals Capital Structure Change
SBI Mutual Fund sold 18,400 shares of Privi Speciality Chemicals Ltd via open market, reducing its stake from 7.3905% to 7.3434%.
Privi Speciality Chemicals Acquisition
Privi Speciality Chemicals announced an NCLT-convened meeting of equity shareholders for October 27, 2026, to consider the proposed Scheme of Amalgamation involving two transferor companies.
Privi Speciality Chemicals Annual General Meeting
Privi Speciality Chemicals Ltd held its 41st Annual General Meeting on August 7, 2026. The meeting covered financial adoption, dividend declaration, and director appointments.
Privi Speciality Chemicals Investor Presentation: Key Takeaways
Privi reported strong Q1 FY27 results with 20.01% YoY revenue growth. Strategy focuses on '5k | 1k' vision via capacity expansion and higher-value specialty molecules.
- Call
- Guides 100% growth
Privi Speciality Chemicals Q1 FY27 Results: Net Profit ₹82.8 Cr, Up 43.7% YoY
Privi Speciality Chemicals Ltd reported revenue from operations of ₹666.2 Cr (+19.2% YoY) and net profit of ₹82.8 Cr (+43.7% YoY) for Q1 FY27.
- Key figure
- Net profit ₹82.8 Cr · +43.7% YoY
Privi Speciality Chemicals Board Meeting Date
Privi Speciality Chemicals Ltd has scheduled a Board Meeting on July 30, 2026, to consider and approve the unaudited financial results for the quarter ended June 30, 2026.